A detailed history of Schonfeld Strategic Advisors LLC transactions in Xencor Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 50,284 shares of XNCR stock, worth $1.26 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
50,284
Previous 134,165 62.52%
Holding current value
$1.26 Million
Previous $2.54 Million 60.18%
% of portfolio
0.01%
Previous 0.02%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.7 - $21.65 $1.32 Million - $1.82 Million
-83,881 Reduced 62.52%
50,284 $1.01 Million
Q2 2024

Aug 14, 2024

SELL
$18.21 - $24.5 $1.09 Million - $1.47 Million
-59,807 Reduced 30.83%
134,165 $2.54 Million
Q1 2024

May 15, 2024

BUY
$18.65 - $26.52 $519,607 - $738,873
27,861 Added 16.77%
193,972 $4.29 Million
Q4 2023

Feb 14, 2024

BUY
$16.53 - $21.42 $2.75 Million - $3.56 Million
166,111 New
166,111 $3.53 Million
Q4 2022

Feb 14, 2023

SELL
$24.79 - $30.86 $146,285 - $182,104
-5,901 Reduced 25.99%
16,800 $437,000
Q3 2022

Nov 14, 2022

BUY
$24.62 - $32.44 $558,898 - $736,420
22,701 New
22,701 $590,000
Q4 2018

Feb 14, 2019

SELL
$32.39 - $42.05 $3.14 Million - $4.07 Million
-96,900 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$35.69 - $47.65 $3.46 Million - $4.62 Million
96,900 New
96,900 $3.78 Million

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.49B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.